Altered splicing of <scp>ATG16‐L1</scp> mediates acquired resistance to tyrosine kinase inhibitors of <scp>EGFR</scp> by blocking autophagy in non‐small cell lung cancer-Reference-Cited by-同舟云学术

Altered splicing of ATG16‐L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non‐small cell lung cancer

Published:2022-08-30 Issue:19 Volume:16 Page:3490-3508
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Hatat Anne‐Sophie¹,Benoit‐Pilven Clara²,Pucciarelli Amélie¹,de Fraipont Florence¹³,Lamothe Lucie¹,Perron Pascal¹,Rey Amandine²,Levra Matteo Giaj¹⁴,Toffart Anne‐Claire¹⁴,Auboeuf Didier²,Eymin Beatrice¹,Gazzeri Sylvie¹^ORCID

Affiliation:

1. Team “RNA Splicing, Cell Signaling and Response to Therapies”, Institute for Advanced Biosciences (IAB) INSERM U1209, CNRS UMR 5309, Grenoble Alpes University France

2. Laboratory of Biology and Modelling of the Cell Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR 5239, INSERM U1210 Lyon France

3. Molecular Genetic Unit Grenoble‐Alpes University Hospital France

4. Thoracic Oncology Unit Grenoble‐Alpes University Hospital France

Funder

Ligue Contre le Cancer

Fondation ARC pour la Recherche sur le Cancer

Institut National Du Cancer

Institut National de la Santé et de la Recherche Médicale

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology